je.st
news
Novavax losses widen on expenses
2015-02-27 03:31:23| Biotech - Topix.net
Gaithersburg-based Novavax Inc., which began early stage clinical trials for an Ebola vaccine, reports wider quarterly losses on an increase in R&D expenses. Gaithersburg-based Novavax Inc. posted higher full year revenue, but rising research and development costs and a growing workforce increased expenses and widened fourth quarter losses.
Tags: expenses
losses
widen
novavax
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||